Later, patients using these drugs reported unexpected weight loss due to reduced appetite, which shifted their use from diabetes treatment to mainstream weight-management therapy
Suplementacja w sporcie jest wana, ale na pewnym etapie moe przesta przynosi zadowalajce efekty
Participants taking Wegovy more frequently reported: nausea diarrhea constipation vomiting The trial also revealed compelling secondary benefits, with improvements in key comorbidities, including: type 2 diabetes obesity cardiovascular risk markers Most notably, people taking Wegovy lost significantly more weight than those receiving a placebo an average of 10% of body weight compared to just 2%
Nearly all PCOS patients prescribed semaglutide or tirzepatide also had obesity or type 2 diabetes, suggesting use remains primarily tied to metabolic indications, though broader interest in PCOS benefits is growing within scientific literature
These include carbonated drinks, high-fiber vegetables (like beans, broccoli, and cabbage), and artificial sweeteners
Cellular Energy and Recovery Your mitochondriathe powerhouses of your cellsare highly susceptible to oxidative stress